Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**TCEAL9 pseudogene 1 (TCEAL9P1)** is classified as a pseudogene, specifically located on chromosome 20p13, and is assigned the HGNC ID 56943[6]. Pseudogenes are genomic DNA sequences similar to normal genes but are non-functional; they typically do not encode functional proteins and thus do not have direct biological functions, disease roles, nor are they therapeutic targets. TCEAL9P1 is related by sequence to the **TCEAL** (Transcription Elongation Factor A Like) family, suggesting a potential origin from genes involved in transcriptional regulation, but as a pseudogene, it has no known protein or RNA product with a defined biological role[3][6]. There are no reported interacting drugs, biomarker uses, or associated safety concerns. **Key points:** - **TCEAL9P1** is not a protein-coding gene and is not considered a therapeutic target[6]. - No evidence of biological function, disease relevance, or clinical application in humans as of current knowledge. - It should not be confused with the related functional gene **TCEAL9** (Transcription Elongation Factor A Like 9), which does encode a protein with a role in transcriptional regulation[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TCEAL9 pseudogene 1 (TCEAL9P1).